Wednesday, July 8, 2026

Drug profile · INN

fish oil

fish oil (SMOFLIPID 20%) is a supplement. Route of administration: intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 4
News articles 0
Drug details — fish oil
US status
approved
Class
Route
INTRAVENOUS
Patents
1
Programs
4
Data quality
0.84

Quick answer

fish oil (SMOFLIPID 20%) is a supplement. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN fish oil
Brand SMOFLIPID 20%
Mechanism Supplement
Route INTRAVENOUS
Formulation EMULSION

Mechanism of action

Supplement

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. CAPTURE Phase 2 · Telethon Foundation · Patients with advanced oncologic disease receiving active tr
  2. Deep-sea fish oil Phase 2 · First People's Hospital · Radiation Toxicity
  3. Lipid Lowering Medication Phase 2 · Grace Therapeutics · Hypertriglyceridemia
  4. Fish Oil Unknown · Summit Therapeutics · Heart Disease

Related patents

  1. US 8460693

    Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is fish oil?

fish oil (SMOFLIPID 20%) is a supplement. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for fish oil?

SMOFLIPID 20% is a marketed brand name for fish oil. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fish oil?

fish oil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.